Related Experiment Video
Updated: Jun 28, 2025

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
Published on: August 2, 2018
Rel Family Transcription Factor NFAT5 Upregulates COX2 via HIF-1α Activity in Ishikawa and HEC1a Cells
Toshiyuki Okumura1,2, Janet P Raja Xavier1, Jana Pasternak1
1Department of Women's Health, Tübingen University Hospital, D-72076 Tübingen, Germany.
Abstract:
Nuclear factor of activated T cells 5 (NFAT5) and cyclooxygenase 2 (COX2; PTGS2) both participate in diverse pathologies including cancer progression. However, the biological role of the NFAT5-COX2 signaling pathway in human endometrial cancer has remained elusive. The present study explored whether NFAT5 is expressed in endometrial tumors and if NFAT5 participates in cancer progression. To gain insights into the underlying mechanisms, NFAT5 protein abundance in endometrial cancer tissue was visualized by immunohistochemistry and endometrial cancer cells (Ishikawa and HEC1a) were transfected with NFAT5 or with an empty plasmid. As a result, NFAT5 expression is more abundant in high-grade than in low-grade endometrial cancer tissue. RNA sequencing analysis of NFAT5 overexpression in Ishikawa cells upregulated 37 genes and downregulated 20 genes. Genes affected included cyclooxygenase 2 and hypoxia inducible factor 1α (HIF1A). NFAT5 transfection and/or treatment with HIF-1α stabilizer exerted a strong stimulating effect on HIF-1α promoter activity as well as COX2 expression level and prostaglandin E2 receptor (PGE2) levels. Our findings suggest that activation of NFAT5-HIF-1α-COX2 axis could promote endometrial cancer progression.
Insights
Nuclear factor of activated T cells 5 (NFAT5) promotes endometrial cancer progression by activating the HIF-1α-COX2 pathway. This pathway
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Nuclear factor of activated T cells 5 (NFAT5) and cyclooxygenase 2 (COX2) are implicated in various pathologies, including cancer.
- The specific role of the NFAT5-COX2 pathway in human endometrial cancer remains unclear.
Purpose of the Study:
- To investigate NFAT5 expression in endometrial tumors.
- To determine if NFAT5 contributes to endometrial cancer progression.
- To elucidate the molecular mechanisms underlying NFAT5's role.
Main Methods:
- Immunohistochemistry to assess NFAT5 protein levels in endometrial cancer tissues.
- Transfection of endometrial cancer cells (Ishikawa, HEC1a) with NFAT5 or empty plasmid.
- RNA sequencing to identify genes regulated by NFAT5.
- Reporter assays to evaluate HIF-1α promoter activity.
Main Results:
- NFAT5 expression is significantly higher in high-grade versus low-grade endometrial cancer.
- NFAT5 overexpression alters the expression of key genes, including cyclooxygenase 2 (COX2) and hypoxia-inducible factor 1α (HIF1A).
- NFAT5 activation stimulates HIF-1α promoter activity, COX2 expression, and prostaglandin E2 (PGE2) levels.
Conclusions:
- The NFAT5-HIF-1α-COX2 signaling axis is activated in endometrial cancer.
- This axis plays a crucial role in promoting endometrial cancer progression.
More Related Videos
Related Concept Videos
Co-activators and Co-repressors
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Cell Specific Gene Expression
Regulation of Angiogenesis and Blood Supply
General Transcription Factors
Master Transcription Regulators

